Memory T-cell immune response in healthy young adults vaccinated with live attenuated influenza A (H5N2) vaccine

Clinical and Vaccine Immunology

Volumn 18, Issue 10, 2011, Pages 1710-1718

  Chirkova, T V ^a   Naykhin, A N ^a   Petukhova, G D ^a   Korenkov, D A ^a   Donina, S A ^a   Mironov, A N ^a   Rudenko, L G ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INFLUENZA VACCINE; LIVE ATTENUATED INFLUENZA A H5N2 VACCINE; LIVE VACCINE; ORVAX; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INTERACTION; CELL MEMBRANE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENETIC REASSORTMENT; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; INFLUENZA A; INFLUENZA A (H5N2); INFLUENZA VIRUS A H2N2; INFLUENZA VIRUS A H5N2; MEMORY T LYMPHOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; RANDOMIZED CONTROLLED TRIAL; STAINING; T LYMPHOCYTE ACTIVATION; TROGOCYTOSIS; VIRUS NEUTRALIZATION; VIRUS STRAIN;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS, H2N2 SUBTYPE; INFLUENZA A VIRUS, H5N2 SUBTYPE; INFLUENZA VACCINES; REASSORTANT VIRUSES; VACCINATION; VACCINES, ATTENUATED; YOUNG ADULT;

EID: 80053460490     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05116-11     Document Type: Article

References (36)

1. Adamopoulou, E., et al. 2007. Human CD4+ T cells displaying viral epitopes elicit a functional virus-specific memory CD8+ T cell response. J. Immunol. 178:5465-5472. (Pubitemid 46674340)
2. Alexandrova, G. I., and A. I. Klimov. 1994. Live influenza vaccine. Nauka, Saint Petersburg, Russia.
3. Beadling, C., and M. K. Slifka. 2006. Quantifying viable virus-specific T cells without a priori knowledge of fine epitope specificity. Nat. Med. 12:1208-1212. (Pubitemid 44527359)
4. Beum, P. V., D. A. Mack, A. W. Pawluczkowycz, M. A. Lindorfer, and R. P. Taylor. 2008. Binding of rituximab, trastuzumab, cetuximab, or mAb T101 to cancer cells promotes trogocytosis mediated by THP-1 cells and monocytes. J. Immunol. 181:8120-8132.
5. Beyer, W. E. P., A. M Palache, G. Luchters, J. Nauta, and A. D. M. E. Osterhaus. 2004. Seroprotection rate, mean fold increase, seroconversion rate: which parameters adequately expresses seroresponse to influenza vaccination? Virus Res. 103:125-132. (Pubitemid 38649071)
6. Brown, D. M., A. M. Dilzer, D. L. Meents, and S. L. Swain. 2006. CD4 T-cell mediated protection from lethal influenza: perforin and antibody-mediated mechanism give a one-two punch. J. Immunol. 177:2888-2898. (Pubitemid 44277804)
7. Cassetti, M. C., J. M. Katz, and J. Wood 2006. Report of a consultation on role of immunological assays to evaluate efficacy of influenza vaccines. Initiative for Vaccine Research and Global Influenza Programme, World Health Organization, Geneva, Switzerland, 25 January 2005. Vaccine 24:541-543. (Pubitemid 43017818)
8. Daubeuf, S., A. L. Puaux, E. Joly, and D. Hudrisier. 2006. A simple trogocytosis-based method to detect, quantify, characterize and purify antigen-specific live lymphocytes by flow cytometry, via their capture of membrane fragments from antigen-presenting cells. Nat. Protoc. 1:2536-2542.
9. Desheva, J. A., et al. 2006. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. Vaccine 24:6859-6866. (Pubitemid 46107188)
10. Fan, S., et al. 2009. Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates PLoS Pathog. 5:e1000409.
11. Gambotto, A., S. M. Barratt-Boyes, M. D. De Jong, G. Neumann, and Y. Kawaoka. 2008. Human infection with highly pathogenic H5N1 influenza virus. Lancet 371:1464-1475. (Pubitemid 351618340)
12. Girard, M., L. Palkonyay, and M. P. Kieny. 2008. Report of the 4th meeting on the evaluation of pandemic influenza prototype vaccines in clinical trials. Vaccine 26:4975-4977.
13. Hayden, F. G., W. A. Howard, L. Palkonyay, and M. P. Kieny. 2009. Report of the 5th meeting on the evaluation of pandemic influenza prototype vaccines in clinical trials: World Health Organization, Geneva, Switzerland, 12-13 February 2009. Vaccine 27:4079-4089.
14. He, X. S., et al. 2008. Baseline levels of influenza-specific CD4 memory T-cells affect T-cell responses to influenza vaccines. PLoS One 3:2574.
15. He, X. S., et al. 2006. Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J. Virol. 80:11756-11766.
16. Hudrisier, D., A. Aucher, A. L. Puaux, C. Bordier, and E. Joly. 2007. Capture of target cell membrane components via trogocytosis is triggered by a selected set of surface molecules on T or B cells. J. Immunol. 178:3637-3647. (Pubitemid 46417631)
17. Joly, E., and D. Hudrisier. 2003. What is trogocytosis and what is its purpose? Nat. Immunol. 4:815. (Pubitemid 37098646)
18. Lee, L. Y., et al. 2008. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J. Clin. Invest. 118:3478-3490.
19. Prussin, C., and D. D. Metcalfe. 1995. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J. Immunol. Methods 188:117-128. (Pubitemid 26011539)
20. Puaux, A. L., et al. 2006. A very rapid and simple assay based on trogocytosis to detect and measure specific T and B cell reactivity by flow cytometry. Eur. J. Immunol. 36:779-788.
21. Rechavi, O., et al. 2007. Intercellular transfer of oncogenic H-Ras at the immunological synapse. PLoS One 2:e1204.
22. Romagnani, S. 1991. Type 1 T helper and type 2 T helper cells: functions, regulation and role in protection and disease. Int. J. Clin. Lab. Res. 21:152-158.
23. Romanova, J., et al. 2009. Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine. PLoS One 4:e5984.
24. Roti, M., et al. 2008. Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus. J. Immunol. 180:1758-1768.
25. Rowe, T., et al. 1999. Detection of antibody to avian influenza A(H5N1) virus in human serum by using a combination of serologic assays. J. Clin. Microbiol. 37:937-943. (Pubitemid 29140593)
26. Rudenko, L., et al. 2008. Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials). Influenza Other Respi. Viruses 2:203-209.
27. Subbarao, K., et al. 2003. Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. Virology 305:192-200. (Pubitemid 36062823)
28. Swain, S. L., et al. 2006. CD4+ T-cell memory: generation and multi-faceted roles for CD4+ T cells in protective immunity to influenza. Immunol. Rev. 211:8-22. (Pubitemid 43882957)
29. Tamura, S., T. Tanimoto, and T. Kurata. 2005. Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines. Jpn. J. Infect. Dis. 58:195-207. (Pubitemid 41460922)
30. Thomas, P. G., R. Keating, D. J. Hulse-Post, and P. C. Doherty. 2006. Cell-mediated protection in influenza infection. Emerg. Infect. Dis. 12:48-54. (Pubitemid 43143535)
31. Ungchusak, K., et al. 2005. Probable person-to-person transmission of avian influenza A (H5N1). N. Engl. J. Med. 352:333-340.
32. Uyeki, T. M. 2008. Global epidemiology of human infections with highly pathogenic avian influenza A (H5N1) viruses. Respirology 13(Suppl. 1):S2-S9. (Pubitemid 351661387)
33. Wang, H., et al. 2008. Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet 371:1427-1434.
34. Welsh, R. M., L. K. Selin, and E. Szomolanyi-Tsuda. 2004. Immunological memory to viral infections. Annu. Rev. Immunol. 22:711-743. (Pubitemid 38680439)
35. World Health Organization. 2011. Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO. World Health Organization, Geneva, Switzerland. http://www.who.int/csr/disease/avian-influenza/country/ cases-table-2011-03-16/en/index.html.
36. World Health Organization. 2005. WHO manual on animal influenza diagnosis and surveillance. WHO/CDS/CSR/NCS/2002.5. World Health Organization, Geneva, Switzerland. http://www.who.int/csr/resources/publications/influenza/ whocdscsrncs20025rev.pdf. Accessed 20 September 2008.